PL3361260T3 - Sposób diagnozowania lub monitorowania czynności nerek lub diagnozowania dysfunkcji nerek - Google Patents
Sposób diagnozowania lub monitorowania czynności nerek lub diagnozowania dysfunkcji nerekInfo
- Publication number
- PL3361260T3 PL3361260T3 PL18164302T PL18164302T PL3361260T3 PL 3361260 T3 PL3361260 T3 PL 3361260T3 PL 18164302 T PL18164302 T PL 18164302T PL 18164302 T PL18164302 T PL 18164302T PL 3361260 T3 PL3361260 T3 PL 3361260T3
- Authority
- PL
- Poland
- Prior art keywords
- diagnosing
- kidney function
- monitoring kidney
- monitoring
- function
- Prior art date
Links
- 230000003907 kidney function Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000012544 monitoring process Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/563—Immunoassay; Biospecific binding assay; Materials therefor involving antibody fragments
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/665—Assays involving proteins derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- G01N2333/70—Enkephalins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12187051 | 2012-10-02 | ||
| EP13170327 | 2013-06-03 | ||
| EP18164302.4A EP3361260B1 (en) | 2012-10-02 | 2013-10-01 | A method for diagnosing or monitoring kidney function |
| EP13776750.5A EP2904403B1 (en) | 2012-10-02 | 2013-10-01 | A method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction |
| PCT/EP2013/070470 WO2014053501A1 (en) | 2012-10-02 | 2013-10-01 | A method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3361260T3 true PL3361260T3 (pl) | 2020-12-14 |
Family
ID=49356398
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18164302T PL3361260T3 (pl) | 2012-10-02 | 2013-10-01 | Sposób diagnozowania lub monitorowania czynności nerek lub diagnozowania dysfunkcji nerek |
| PL13776750T PL2904403T3 (pl) | 2012-10-02 | 2013-10-01 | Sposób rozpoznawania lub monitorowania funkcji nerki lub rozpoznawania dysfunkcji nerki |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13776750T PL2904403T3 (pl) | 2012-10-02 | 2013-10-01 | Sposób rozpoznawania lub monitorowania funkcji nerki lub rozpoznawania dysfunkcji nerki |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US9664695B2 (pl) |
| EP (2) | EP3361260B1 (pl) |
| JP (2) | JP6307509B2 (pl) |
| CN (1) | CN104769433B (pl) |
| CA (1) | CA2886779C (pl) |
| DK (2) | DK2904403T3 (pl) |
| ES (2) | ES2674822T3 (pl) |
| HK (1) | HK1212436A1 (pl) |
| PL (2) | PL3361260T3 (pl) |
| RU (2) | RU2707303C1 (pl) |
| TR (1) | TR201809001T4 (pl) |
| WO (1) | WO2014053501A1 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10316053B2 (en) * | 2012-10-11 | 2019-06-11 | Armaron Bio Pty Ltd | Flavonoid compounds and uses thereof |
| US11598781B2 (en) * | 2015-04-24 | 2023-03-07 | Sphingotec Gmbh | Method for predicting the risk of incidence of chronic kidney disease |
| SG11201810261UA (en) * | 2016-05-17 | 2018-12-28 | Univ Osaka | Kidney disease prognosis prediction method and system |
| RU2653817C1 (ru) * | 2016-11-23 | 2018-05-14 | федеральное государственное бюджетное образовательное учреждение высшего образования "Ульяновский государственный университет" | Способ прогнозирования острого повреждения почек у больных с инсультом |
| US20200182885A1 (en) * | 2017-05-30 | 2020-06-11 | Sphingotec Gmbh | A method for diagnosing or monitoring kidney function or diagnosing kidney dysfuntion |
| EP4014049A1 (en) * | 2019-08-15 | 2022-06-22 | sphingotec GmbH | A method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction in pediatric patients |
| RU2753588C1 (ru) * | 2020-10-05 | 2021-08-18 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Оренбургский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ диагностики доклинической стадии вторичных нефропатий у детей |
| RU2767701C1 (ru) * | 2020-12-16 | 2022-03-18 | Надежда Владимировна Агранович | Способ ранней диагностики эндотелиальной дисфункции почек у больных хронической обструктивной болезнью легких |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU634716B2 (en) | 1988-08-01 | 1993-03-04 | Ciba Corning Diagnostics Corp. | Method for detection of an analyte using acridinium esters and liposomes |
| US6818418B1 (en) | 1998-12-10 | 2004-11-16 | Compound Therapeutics, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
| US20040023334A1 (en) | 2001-08-30 | 2004-02-05 | Biorexis Pharmaceutical Corporation | Modified transferrin fusion proteins |
| US20040014143A1 (en) * | 2002-05-29 | 2004-01-22 | Haskins William E. | Method and apparatus for detecting and monitoring peptides, and peptides identified therewith |
| EP2298278B1 (en) | 2002-06-07 | 2015-11-11 | Dyax Corp. | Prevention and reduction of blood loss and inflammatory response |
| AU2004284090A1 (en) | 2003-10-24 | 2005-05-06 | Avidia, Inc. | LDL receptor class A and EGF domain monomers and multimers |
| US20100028995A1 (en) | 2004-02-23 | 2010-02-04 | Anaphore, Inc. | Tetranectin Trimerizing Polypeptides |
| ES2431288T3 (es) * | 2004-05-13 | 2013-11-25 | B.R.A.H.M.S Gmbh | Uso de precursores de encefalinas y/o sus fragmentos en diagnosis médica |
| EP1793847A2 (en) | 2004-09-21 | 2007-06-13 | NascaCell IP GmbH | Use of microproteins as tryptase inhibitors |
| CN101680903A (zh) * | 2007-03-21 | 2010-03-24 | 比奥波托诊断股份公司 | 肾损伤的诊断试验 |
| WO2009077175A1 (en) | 2007-12-19 | 2009-06-25 | Affibody Ab | Polypeptide derived from protein a and able to bind pdgf |
| JP5954990B2 (ja) | 2008-11-03 | 2016-07-20 | モレキュラー・パートナーズ・アーゲーＭｏｌｅｃｕｌａｒ Ｐａｒｔｎｅｒｓ Ａｇ | Ｖｅｇｆ−ａレセプター相互作用を阻害する結合タンパク質 |
| MY162697A (en) * | 2008-11-21 | 2017-07-14 | Future Medical Diagnostics Co Ltd | Methods, devices and kits for detecting or monitoring acute kidney injury |
| NZ598351A (en) | 2009-08-27 | 2014-08-29 | Covagen Ag | Il-17 binding compounds and medical uses thereof |
| WO2011073209A1 (en) | 2009-12-14 | 2011-06-23 | Scil Proteins Gmbh | Modified ubiquitin proteins having a specific binding activity for the extradomain b of fibronectin |
| NZ603562A (en) | 2010-06-08 | 2014-07-25 | Pieris Ag | Tear lipocalin muteins binding il-4 r alpha |
| CA2802273A1 (en) | 2010-08-06 | 2012-02-09 | Pronota N.V. | Perlecan as a biomarker for renal dysfunction |
| CN102636652A (zh) * | 2012-04-18 | 2012-08-15 | 苏州大学 | 尿液中可溶性Corin在慢性肾病诊断中的应用 |
-
2013
- 2013-10-01 JP JP2015534991A patent/JP6307509B2/ja active Active
- 2013-10-01 CA CA2886779A patent/CA2886779C/en active Active
- 2013-10-01 EP EP18164302.4A patent/EP3361260B1/en active Active
- 2013-10-01 WO PCT/EP2013/070470 patent/WO2014053501A1/en active Application Filing
- 2013-10-01 TR TR2018/09001T patent/TR201809001T4/tr unknown
- 2013-10-01 PL PL18164302T patent/PL3361260T3/pl unknown
- 2013-10-01 RU RU2019103538A patent/RU2707303C1/ru active
- 2013-10-01 ES ES13776750.5T patent/ES2674822T3/es active Active
- 2013-10-01 PL PL13776750T patent/PL2904403T3/pl unknown
- 2013-10-01 DK DK13776750.5T patent/DK2904403T3/en active
- 2013-10-01 CN CN201380051659.3A patent/CN104769433B/zh active Active
- 2013-10-01 EP EP13776750.5A patent/EP2904403B1/en active Active
- 2013-10-01 US US14/432,957 patent/US9664695B2/en active Active
- 2013-10-01 RU RU2015116674A patent/RU2679913C2/ru active
- 2013-10-01 ES ES18164302T patent/ES2810001T3/es active Active
- 2013-10-01 DK DK18164302.4T patent/DK3361260T3/da active
-
2016
- 2016-01-07 HK HK16100134.9A patent/HK1212436A1/xx unknown
-
2017
- 2017-05-09 US US15/590,571 patent/US10114029B2/en active Active
-
2018
- 2018-03-12 JP JP2018043894A patent/JP6669794B2/ja active Active
- 2018-10-29 US US16/173,236 patent/US11016107B2/en active Active
-
2021
- 2021-05-24 US US17/328,100 patent/US20210333292A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US10114029B2 (en) | 2018-10-30 |
| HK1212436A1 (en) | 2016-06-10 |
| RU2679913C2 (ru) | 2019-02-14 |
| CN104769433A (zh) | 2015-07-08 |
| DK2904403T3 (en) | 2018-07-16 |
| JP6669794B2 (ja) | 2020-03-18 |
| RU2015116674A (ru) | 2016-11-27 |
| JP2015535936A (ja) | 2015-12-17 |
| CA2886779A1 (en) | 2014-04-10 |
| US9664695B2 (en) | 2017-05-30 |
| ES2810001T3 (es) | 2021-03-08 |
| US11016107B2 (en) | 2021-05-25 |
| US20150260732A1 (en) | 2015-09-17 |
| EP2904403B1 (en) | 2018-03-28 |
| PL2904403T3 (pl) | 2018-08-31 |
| EP3361260A1 (en) | 2018-08-15 |
| US20170261522A1 (en) | 2017-09-14 |
| JP2018141788A (ja) | 2018-09-13 |
| EP2904403A1 (en) | 2015-08-12 |
| JP6307509B2 (ja) | 2018-04-04 |
| CN104769433B (zh) | 2018-07-27 |
| RU2707303C1 (ru) | 2019-11-26 |
| WO2014053501A1 (en) | 2014-04-10 |
| TR201809001T4 (tr) | 2018-07-23 |
| EP3361260B1 (en) | 2020-06-10 |
| CA2886779C (en) | 2022-11-01 |
| ES2674822T3 (es) | 2018-07-04 |
| US20210333292A1 (en) | 2021-10-28 |
| US20190049470A1 (en) | 2019-02-14 |
| DK3361260T3 (da) | 2020-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2505324B (en) | A monitoring system | |
| HK1208139A1 (en) | A monitoring device | |
| EP2906697A4 (en) | METHODS OF MONITORING C9ORF72 EXPRESSION | |
| EP2778698A4 (en) | BATTERY CONDITION MONITORING SYSTEM | |
| EP2819567A4 (en) | SEHKRAFTTESTSYSTEM | |
| EP2913601A4 (en) | MONITORING SYSTEM | |
| GB201112161D0 (en) | Portal monitoring | |
| EP2923346A4 (en) | MEDICAL SURVEILLANCE SYSTEM | |
| GB201502811D0 (en) | A driving behaviour monitoring system | |
| GB201205707D0 (en) | Vehicle monitoring system tool | |
| GB201215649D0 (en) | System monitoring | |
| PL3361260T3 (pl) | Sposób diagnozowania lub monitorowania czynności nerek lub diagnozowania dysfunkcji nerek | |
| GB201400942D0 (en) | A monitoring device | |
| EP2834796A4 (en) | MONITORING SYSTEM | |
| SG2013075700A (en) | Methods and systems for monitoring a petroleumreservoir | |
| EP2801081A4 (en) | MONITORING OF AN OBJECT | |
| GB2503610B (en) | Method for monitoring seafloor movements | |
| GB201204789D0 (en) | System monitoring | |
| HK1202980A1 (zh) | 種步進開關監控方法 | |
| EP2762076A4 (en) | ANALYTÜBERWACHUNGSSYSTEM | |
| IL232355A0 (en) | A method for determining calcification tendency | |
| EP2875234A4 (en) | DIAGNOSTICS FOR A STARTING SYSTEM | |
| SG2012068490A (en) | A relay for automatically selecting a monitoring range | |
| GB201215371D0 (en) | Monitoring software | |
| PL2677374T3 (pl) | Sposób monitorowania instalacji grzewczej |